Method of selecting stem cells having high chondrogenic differentiation capability
US9040298B2 · kind B2 · utility
0Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 28, 2010 |
| Grant date | May 26, 2015 |
| Priority date | — |
| Expiry date | Oct 12, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/5005
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Thrombospondin 1 (TSP-1), TSP-2, interleukin 17B receptor (IL-17BR) and heparin-binding epidermal growth factor-like growth factor (HB-EGF) associated with stem cell activity and use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.